This content is only available within our institutional offering.
01 Feb 2018
LIBERUM: Roche - Underlying guidance a touch weak, expect upgrades through year - headline guidance well ahead on US tax
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Roche - Underlying guidance a touch weak, expect upgrades through year - headline guidance well ahead on US tax
Roche Holding Ltd Dividend Right Cert. (RHO5:ETR) | 0 0 1.1% | Mkt Cap: 194,207m
- Published:
01 Feb 2018 -
Author:
Graham Doyle -
Pages:
3